BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36544211)

  • 21. The effect of soy phytoestrogen supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: a randomized, double-blind, crossover study.
    Sathyapalan T; Manuchehri AM; Thatcher NJ; Rigby AS; Chapman T; Kilpatrick ES; Atkin SL
    J Clin Endocrinol Metab; 2011 May; 96(5):1442-9. PubMed ID: 21325465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy-A Randomized, Double-blind, Placebo-controlled Clinical Trial.
    Murtola TJ; Syvälä H; Tolonen T; Helminen M; Riikonen J; Koskimäki J; Pakarainen T; Kaipia A; Isotalo T; Kujala P; Tammela TLJ
    Eur Urol; 2018 Dec; 74(6):697-701. PubMed ID: 30031572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Prostate Cancer Intervention Versus Observation Trial: VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy with watchful waiting for men with clinically localized prostate cancer.
    Wilt TJ
    J Natl Cancer Inst Monogr; 2012 Dec; 2012(45):184-90. PubMed ID: 23271771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Dietary Phytoestrogens on Hormones throughout a Human Lifespan: A Review.
    Domínguez-López I; Yago-Aragón M; Salas-Huetos A; Tresserra-Rimbau A; Hurtado-Barroso S
    Nutrients; 2020 Aug; 12(8):. PubMed ID: 32824177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemotherapeutic Activities of Dietary Phytoestrogens against Prostate Cancer: From Observational to Clinical Studies.
    Sohel M; Sultana H; Sultana T; Mamun AA; Amin MN; Hossain MA; Ali MC; Aktar S; Sultana A; Rahim ZB; Mitra S; Dash R
    Curr Pharm Des; 2022; 28(19):1561-1580. PubMed ID: 35652403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data.
    Vale CL; Fisher D; Kneebone A; Parker C; Pearse M; Richaud P; Sargos P; Sydes MR; Brawley C; Brihoum M; Brown C; Chabaud S; Cook A; Forcat S; Fraser-Browne C; Latorzeff I; Parmar MKB; Tierney JF;
    Lancet; 2020 Oct; 396(10260):1422-1431. PubMed ID: 33002431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genome-wide DNA methylation modified by soy phytoestrogens: role for epigenetic therapeutics in prostate cancer?
    Karsli-Ceppioglu S; Ngollo M; Adjakly M; Dagdemir A; Judes G; Lebert A; Boiteux JP; Penault-LLorca F; Bignon YJ; Guy L; Bernard-Gallon D
    OMICS; 2015 Apr; 19(4):209-19. PubMed ID: 25831061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.
    Vickers AJ; Cronin AM; Aus G; Pihl CG; Becker C; Pettersson K; Scardino PT; Hugosson J; Lilja H
    Cancer; 2010 Jun; 116(11):2612-20. PubMed ID: 20336781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementation.
    Rannikko A; Petas A; Rannikko S; Adlercreutz H
    Prostate; 2006 Jan; 66(1):82-7. PubMed ID: 16114063
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostate cancer chemoprevention: Strategies for designing efficient clinical trials.
    Lieberman R
    Urology; 2001 Apr; 57(4 Suppl 1):224-9. PubMed ID: 11295633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase III randomised controlled trial on PSMA PET/CT guided hypofractionated salvage prostate bed radiotherapy of biochemical failure after radical prostatectomy for prostate cancer (PERYTON-trial): study protocol.
    Staal FHE; Janssen J; Brouwer CL; Langendijk JA; Ng Wei Siang K; Schuit E; de Jong IJ; Verzijlbergen JF; Smeenk RJ; Aluwini S
    BMC Cancer; 2022 Apr; 22(1):416. PubMed ID: 35428210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current concepts and significance of estrogen receptor β in prostate cancer.
    Hartman J; Ström A; Gustafsson JÅ
    Steroids; 2012 Oct; 77(12):1262-6. PubMed ID: 22824289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between dietary phytoestrogens intakes and prostate cancer risk in Sicily.
    Russo GI; Di Mauro M; Regis F; Reale G; Campisi D; Marranzano M; Lo Giudice A; Solinas T; Madonia M; Cimino S; Morgia G
    Aging Male; 2018 Mar; 21(1):48-54. PubMed ID: 28817364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phytoestrogens and prostate cancer risk.
    Ganry O
    Prev Med; 2005 Jul; 41(1):1-6. PubMed ID: 15916986
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soy consumption and phytoestrogens: effect on serum prostate specific antigen when blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic men.
    Jenkins DJ; Kendall CW; D'Costa MA; Jackson CJ; Vidgen E; Singer W; Silverman JA; Koumbridis G; Honey J; Rao AV; Fleshner N; Klotz L
    J Urol; 2003 Feb; 169(2):507-11. PubMed ID: 12544298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dietary phytoestrogen intake is associated with reduced colorectal cancer risk.
    Cotterchio M; Boucher BA; Manno M; Gallinger S; Okey A; Harper P
    J Nutr; 2006 Dec; 136(12):3046-53. PubMed ID: 17116718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer.
    Ilic D; Evans SM; Allan CA; Jung JH; Murphy D; Frydenberg M
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD009625. PubMed ID: 28895658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phytoestrogens for vasomotor menopausal symptoms.
    Lethaby AE; Brown J; Marjoribanks J; Kronenberg F; Roberts H; Eden J
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001395. PubMed ID: 17943751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer.
    Wilt TJ; Brawer MK
    J Urol; 1994 Nov; 152(5 Pt 2):1910-4. PubMed ID: 7523736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.